Skip to content
Screener

Ciena CIEN Restructuring and Asset Impairment Charges

Restructuring and Asset Impairment Charges at other companies

Howmet Aerospace logo
Howmet AerospaceHWM
-$93M-2,225%
Ciena logo
CienaCIEN
$1.5M-3.0%
Xylem logo
XylemXYL
$31M+47.6%
Smurfit Kappa Group logo
Smurfit Kappa GroupSW
$54M+260%
Staar Surgical logo
Staar SurgicalSTAA
$2.68M-88.2%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$796K+371%

Other financials

Income statement

See full
Revenue$1.6B+39.5%
Gross profit$691.6M+52.7%
Operating income$237.9M+624%
Net income$218.2M+2,333%
EPS (diluted)$1.49+2,383%

Balance sheet

See full
Cash & equivalents$1.0B+10.0%
Total debt$1.6B-0.8%
Total equity$2.9B+4.2%
Total assets$6.0B+6.7%

Cash flow

See full
Operating cash flow$259.7M+65.5%
CapEx$41.0M+42.8%
Free cash flow$218.7M+70.5%

Valuation

See full
Market cap$57.87B+334%
Enterprise value$58.4B+321%
P/E132×+37.4×
P/S10.4×+7.5×

Profitability

See full
Gross margin43%+1.1pp
Operating margin9.2%+4.5pp
Net margin7.9%+5.4pp
FCF margin15%—

Returns & leverage

See full
Return on equity15.5%+11.8pp
Debt / equity0.5×0.0×
Current ratio2.7×-0.7×